NatureWise Biotech & Medicals Corporation (TPEX:4732)

TPEX:4732 Balance Sheet

Financials in millions TWD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	319.95	112.55	98.97	155.56	162.57
Short-Term Investments	294.78	362.71	344.41	292.02	259.37
Trading Asset Securities	-	-	50.6	50.29	50.2
Cash & Short-Term Investments	614.73	475.26	493.98	497.87	472.13
Cash Growth	29.35%	-3.79%	-0.78%	5.45%	17.19%
Accounts Receivable	56.73	55.17	64.35	65.48	60.02
Other Receivables	1.61	1.93	-	-	0.05
Receivables	58.35	57.1	64.35	65.48	60.07
Inventory	84.37	82.5	59.56	55.8	37.71
Prepaid Expenses	-	-	4.15	-	-
Other Current Assets	13.22	12.15	0.23	4.63	5.42
Total Current Assets	770.67	627.01	622.26	623.77	575.33
Property, Plant & Equipment	3.96	8.62	3.63	8.26	5.33
Goodwill	8.54	8.54	8.54	8.54	8.54
Other Intangible Assets	22.85	28.84	33.97	38.93	43.71
Long-Term Deferred Tax Assets	28.44	20.16	19.14	19.4	18.89
Other Long-Term Assets	6.13	5.28	5.06	5.66	6.44
Total Assets	840.59	698.45	692.6	704.57	658.24
Accounts Payable	12.97	22.98	8.8	22.99	1.79
Accrued Expenses	13.54	15.43	22.41	30.53	35.28
Current Portion of Leases	3.35	4.52	2.7	3.94	2.74
Current Income Taxes Payable	8.39	0.1	0.68	1.33	0.1
Current Unearned Revenue	6.51	5.67	4.34	7.49	7.85
Other Current Liabilities	5.68	5.59	3.92	2.09	2.11
Total Current Liabilities	50.44	54.29	42.85	68.37	49.87
Long-Term Leases	0.06	3.27	-	2.7	-
Long-Term Deferred Tax Liabilities	2.54	3.33	4.24	5.15	6.06
Other Long-Term Liabilities	4	4	4	4	4
Total Liabilities	57.03	64.89	51.09	80.22	59.93
Common Stock	492.9	492.9	492.9	492.9	465
Additional Paid-In Capital	193.65	77.67	70.84	69.13	69.13
Retained Earnings	55.33	64.29	78.81	63.57	65.32
Comprehensive Income & Other	-0.86	-1.29	-1.04	-1.26	-1.14
Total Common Equity	741.02	633.56	641.51	624.35	598.31
Minority Interest	42.54	-	-	-	-
Shareholders' Equity	783.56	633.56	641.51	624.35	598.31
Total Liabilities & Equity	840.59	698.45	692.6	704.57	658.24
Total Debt	3.4	7.78	2.7	6.64	2.74
Net Cash (Debt)	611.33	467.48	491.28	491.23	469.39
Net Cash Growth	30.77%	-4.84%	0.01%	4.65%	18.51%
Net Cash Per Share	12.27	9.37	9.93	9.96	9.51
Filing Date Shares Outstanding	49.29	49.2	49.29	49.29	49.29
Total Common Shares Outstanding	49.29	49.2	49.29	49.29	49.29
Working Capital	720.23	572.72	579.42	555.41	525.46
Book Value Per Share	15.03	12.88	13.02	12.67	12.14
Tangible Book Value	709.62	596.18	599	576.88	546.06
Tangible Book Value Per Share	14.40	12.12	12.15	11.70	11.08
Machinery	7.7	7.58	7.58	7.61	7.61
Leasehold Improvements	5.19	5.19	4.88	5.08	5.08

Updated Aug 13, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.